Welcome to our dedicated page for Establishment Labs Holdings news (Ticker: ESTA), a resource for investors and traders seeking the latest updates and insights on Establishment Labs Holdings stock.
Establishment Labs Holdings Inc. (ESTA) is a leading global medical technology company, renowned for its innovation in the field of medical devices and aesthetics. Specializing in advanced silicone-filled breast and body shaping implants, the company has over 30 years of experience in breast implant manufacturing. Establishment Labs designs, develops, manufactures, and markets an extensive product portfolio that ensures safety and meets the current needs and preferences of plastic surgeons and patients.
Known for its flagship product, Motiva Implants®, Establishment Labs has set a benchmark in the industry for product innovation and safety. The company operates in multiple geographical segments, including Europe, Latin America, Asia-Pacific/Middle East, and other regions. Establishment Labs' products are distributed to medical distributors, physicians, hospitals, and clinics through direct sales channels.
Recent achievements include the continued global expansion of the Motiva Implants® brand and strategic partnerships aimed at advancing medical and aesthetic technology. With a strong focus on the future, the company is dedicated to pushing the boundaries of innovation and safety in medical devices.
Establishment Labs maintains a robust financial condition, driven by its commitment to quality and continuous improvement. The company’s ongoing projects include research and development initiatives aimed at introducing new and improved products that align with market demands.
For the latest updates and relevant information about Establishment Labs Holdings Inc., stay tuned to this page for the most recent news and developments.
Establishment Labs (NASDAQ: ESTA), a leader in medical technology focused on women's health, announced its participation in two key investment conferences. CEO Juan José Chacón-Quirós and CFO Raj Denhoy will present at the Jefferies Global Healthcare Conference on June 5, 2024, and the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024. Live webcasts of their presentations will be accessible via the company's investor relations website. Establishment Labs is renowned for its Femtech solutions, including the Motiva® breast implants and Motiva Flora® tissue expanders, with a presence in over 85 countries. The company's innovations are backed by extensive patent applications and scientific research, and its manufacturing facilities in Costa Rica comply with stringent regulatory standards.
Establishment Labs Holdings Inc. (NASDAQ: ESTA) reported first quarter 2024 financial results, with worldwide revenue of $37.2 million. The 2024 revenue guidance is $174 million to $184 million, reflecting a 5% to 11% increase over 2023. Gross profit was $24.4 million, with a loss from operations of $8.8 million. Adjusted EBITDA loss improved to $3.7 million. The company's cash balance was $73.0 million as of March 31, 2024. Establishment Labs presented 4-year results from Motiva® U.S. IDE study showing positive outcomes, aiming for FDA approval of Motiva Implants in 2024.
Establishment Labs Holdings Inc. noted the presentation of 4-year results from the Motiva US IDE Study at The Aesthetic Meeting 2024. Dr. Caroline Glicksman presented data for 451 primary augmentation patients, showing low complication rates and high patient follow-up, with Motiva implants potentially becoming a new standard in breast aesthetics.
Establishment Labs Holdings Inc. (NASDAQ: ESTA) announces the appointment of Jeff Ehrhardt as the General Manager of North America. Mr. Ehrhardt brings over 25 years of experience from Allergan Aesthetics, with the responsibility of launching Motiva implants in the U.S. to set new standards in breast aesthetics and reconstruction. The move signifies a significant step for Establishment Labs in expanding its global presence and enhancing women's health and wellness.
FAQ
What is the current stock price of Establishment Labs Holdings (ESTA)?
What is the market cap of Establishment Labs Holdings (ESTA)?
What does Establishment Labs Holdings Inc. specialize in?
What is the flagship product of Establishment Labs?
In which regions does Establishment Labs operate?
How does Establishment Labs distribute its products?
What are the recent achievements of Establishment Labs?
What is the focus of Establishment Labs' ongoing projects?
How long has Establishment Labs been in the breast implant manufacturing industry?
What sets Motiva Implants® apart from other products in the market?
Is Establishment Labs a publicly traded company?
Where can I find the latest news about Establishment Labs Holdings Inc.?
